Shortly before the end of his tenure as Chair of the US Securities and Exchange Commission (SEC), Chair Jay Clayton presided over the SEC as it considered and approved the New York Stock Exchange’s (NYSE) proposed rule change modifying the NYSE’s rules in order to permit, as described in this Legal Update, primary issuances in

In the International Financial Law Review’s latest publication, A Deep Dive Into Capital Raising Alternatives, Mayer Brown provides context on the changes in market structure and market dynamics that led to the enactment of the JOBS Act. Specifically, the trend for many private companies to remain private longer, defer or dispense with traditional

Private investment in public equity (“PIPE”) transactions completed in 2020* have raised over $53.0 billion, in aggregate, in 1055 transactions.  This is the largest sum of capital raised in PIPE transactions since 2008.  While industrials companies (chemicals, metals, mining and paper-focused companies) lead the market by number of PIPEs completed, the 323 deals in this

Monday, September 21, 2020 and Tuesday, September 22, 2020
Register here.

The PLI Pocket MBA is for attorneys representing clients in the financial industry. This two-day program is designed to improve your understanding of business strategies, accounting fundamentals and vocabulary used by management, investors, auditors and bankers.

Partner Jen Carlson, co-chair of the event,

On August 31, 2020, the Securities and Exchange Commission (the “SEC”) notified the New York Stock Exchange (the “NYSE”) that it received a notice of intention to petition for review of the NYSE’s recently approved rule (see our prior post) that would allow companies to conduct limited primary sales concurrent with a direct listing.  

On August 26, 2020, the Securities and Exchange Commission (the “SEC”) approved the proposal submitted by the New York Stock Exchange (“NYSE”) that allows companies to conduct concurrent primary offerings as part of a direct listing on that exchange.  A company may issue new shares and sell them to the public on its first trading

CBInsights recently hosted a webcast, The State of Healthcare Q2 2020. Capital raising by companies in the global healthcare sector yielded a historic high of $18.1 billion in the second quarter of 2020, and deal volume rose 6% quarter-over-quarter. Total funding was boosted by six mega-rounds, or capital raises over $100 million, in the regenerative

PIPE transactions continue to be a popular capital raising approach for companies.  Through July 31, 2020, companies have raised over $47.2 billion in 779 PIPE transactions.  Healthcare and life sciences companies raised almost $11 billion in PIPE transactions.  Technology and industrials companies also raised significant amounts of capital, totaling $10.1 billion and $9.2 billion, respectively.

Maybe still the single best measure ever adopted in order to facilitate capital formation, the shelf registration statement provides an issuer with the most flexibility to take advantage of windows of opportunity and to access the capital markets quickly and efficiently.  We discuss eligibility to use a shelf registration statement, the shelf registration process, and

PIPE transactions were created to be an effective capital raising approach for public companies when there were few, if any, other satisfactory financing alternatives. While there are now a number of other confidentially marketed securities offering methodologies, for the reasons discussed in this article, PIPE transactions may be the most efficient or only alternative for